TRINITY LIFE SCIENCES ACQUIRES D CUBE ANALYTICS

Home / Intelligence / News / TRINITY LIFE SCIENCES ACQUIRES D CUBE ANALYTICS

Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio

Waltham, MA, July 19, 2022 Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.

“Our strategy to revolutionize the life sciences commercial model includes embracing data science. D Cube brings us high-value, innovative technology platforms that will allow our clients to accelerate their brand strategies,” said David Fitzhenry, CEO of Trinity Life Sciences. “We are excited to add the D Cube team and their best-in-class offerings to our business.”

“The amount of innovation in the life sciences analytics space for the commercialization of products is growing at an exponential rate,” said Neal Dunn, Senior Partner, Analytics. “The D Cube acquisition allows Trinity to accelerate our already growing analytics practice with more deployable technology and proven machine learning models. It also provides Trinity with the scale and tools to help our clients shape and define how and when they should use analytics in a meaningful way – strong analytics will be key to all successful brands.”

“The synergies that D Cube and Trinity share are clear,” said Vijay Nandakumar, co-founder and CEO of D Cube Analytics. “Life sciences companies are at the cusp of a data science revolution where the needs go far beyond clean, transparent and easy-to-manage data. The focus is on insights and speed of responsiveness to market dynamics. Our suite of capabilities combined with Trinity’s strategic therapeutic and commercial expertise offer clients the total package.”

“It was important for us to find a company that had a similar culture as D Cube Analytics and put clients first. Trinity’s purpose – every decision impacts a life – really spoke to us and aligned with our goals,” said Dr. Ajay Chandhok, co-founder and President of D Cube Analytics. “We all know why we get up in the morning – to help life sciences companies make decisions that bring successful life-changing and life-saving treatments to market.”

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.